Example collocations logo

Therapies in sentence

141 examples of Therapies in a sentence

The film suggests that the medical doctors are not able to treat any patient and that paramedical therapies are much more useful.
Funders and policymakers who keep up with the relevant research are slowly beginning to introduce more talking therapies (such as cognitive therapy and trauma-focused counseling), more alternatives to hospitalization, more culturally appropriate services, more family-focused therapy and, most importantly, more genuine consultation with service users about what actually works.
Medical professionals know how often seemingly promising new therapies turn out, after careful study, not to work, or even to be harmful.
There is a rigorous process of scholarly review of proposed new therapies, associated with professional journals that uphold high research standards.
It would be relatively cheap and simple, involving expanded distribution of insecticide-treated bed nets, more preventive treatment for pregnant women, increased use of the maligned pesticide DDT, and support for poor nations that cannot afford the best new therapies.
In targeted therapies, in which drugs interfere with the molecular signaling needed for proliferation and survival, a cell might adapt by activating or following alternative pathways.
When a large number of sensitive cells are killed, say, by aggressive therapies, resistant types can proliferate unconstrained.
Of course, cancer researchers should not abandon their search for ever-more-effective cancer therapies, even for cures.
Other libel suits involved unproven cancer therapies.
Today’s transformational advances in health care owe much to new genomics information, to the availability of big data to influence decisions in real time, to more targeted and individualized therapies, and to smarter, more connected delivery systems.
The medical community has come to accept the need for systematic reviews to guide decisions regarding drugs and surgical therapies, but their use in health policy is only now taking hold.
Some of these therapies can provide additional months or even years of life to people in their prime.
Another is advancing drug therapies tailored to the needs of individual patients.
That promises not only more timely and effective therapies for cancer, but also similar advances against other currently intractable diseases.
Patients can receive discounted flu vaccines, nicotine replacement therapies, help in enrolling in pulmonary rehabilitation sessions, and health information sent to their homes.
Last year, Chisti and his team, in collaboration with colleagues from Australia and with funding from the Australian Agency for International Development, conducted a clinical trial in Bangladesh to compare the efficacy of this alternative apparatus to the low- and high-flow oxygen therapies recommended by the World Health Organization in resource-poor contexts.
Bubble CPAP delivered with the ultra-low cost apparatus was shown to be as effective as the standard low- and high-flow oxygen therapies.
For example, mutations, or defects, at specific molecular locations in human DNA were found to be responsible for some cancers, raising the hope of developing successful therapies tailored to individual patients.
But research involving two new techniques – stem-cell and gene therapies – appears promising.
If those funds are to support effective treatments, they should be channeled into further clinical trials, including of stem cells and gene therapies.
Despite decades of promises, tests are available far in advance of therapies.
But the ethical problems that these technologies pose are conceptually similar to those presented by existing therapies, such as antidepressants.
There are plenty of data on male sexuality and the male brain, and sound new science on the mind-body connection is transforming medical practice, from cardiology’s use of meditation to the use of talk therapies in treating breast cancer.
While these therapies are being developed, we are also working on a strategy to ensure that patients in malaria-endemic countries can afford them, and to improve the effectiveness of our response by identifying areas where malaria takes the greatest toll.
Taking these developments a step further, the Precision Medicine Initiative, launched in the US last year, is pursuing innovative trials of targeted drugs for adult and pediatric cancers, introducing customized combination therapies, and honing its understanding of drug resistance.
That system would suggest surprising, effective therapies, because it would understand disease in ways that are difficult for humans to imagine.
When the BRCA1 and BRCA2 genes were discovered more than a decade ago, there were high hopes for novel and targeted therapies.
Further simulations suggest that funds specializing in some drug classes, such as therapies for orphan diseases, could achieve double-digit rates of return with just $250-500 million dollars and fewer compounds in the portfolio.
Needless to say, digital technologies will also be driving the next wave of life-changing therapies.
This includes: funds to stop the transmission of AIDS from mothers to infants; funds to help fight infections such as tuberculosis that accompany AIDS; and with good program design, even funds for anti-retroviral therapies.
Back